FOR MEN ONLY: New Clinical Trial Seeks Male Volunteers
The primary objective for this study is to evaluate the safety of and record the full effects of a new human growth hormone for men. The study is randomized, vehicle-controlled, ascending multiple dose, placebo-controlled, clinical proof-of-concept, phase 2 study to evaluate the safety, efficacy, tolerability, pharmacokinetics, pharmacodynamics, and physiological effects of Virilimax® administered subcutaneously in adult male patients. Full nudity of volunteers is required.
(Note: All nurse practitioners involved in carrying out the methods of the study are professionals, and any inappropriate behavior by volunteers will not be tolerated. Volunteers will be provided with a digital copy of the 542-page disclosure document listing all possible side effects.)
Want to be the first to hear of new posts like this one?
SIGN UP now to get the special treatment with pics and updates delivered right to your inbox.